Trial
NCT03685253
Nicotinamide Riboside for Diabetic Neuropathy
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Maryland, Baltimore
Collaborators
US Department of Veterans Affairs
Condition
Diabetic Neuropathy Peripheral
Intervention
Niagen
Why stopped
Completed the pilot study and grant funding not obtained to continue to the main phase 2 study. The pilot study did not show a statistical significance in the primary or secondary outcome measures.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-06